Celling Biosciences

Celling Biosciences is a market leader in the biotechnology industry, focusing on the science, R&D, and education of autologous cellular therapy and its synergies. Founded in 2006 and headquartered in the United States, the company is dedicated to advancing the future of medicine through the innovation of point-of-care, autologous regenerative cell therapies. The company's slogan succinctly captures its core focus on advancing the science and research of autologous cellular therapy. Celling Biosciences' commitment to innovation is evident in its description, highlighting their team's dedication to developing point-of-care systems, innovative surgical techniques, and technology platforms to create the optimal environment for regenerative cell therapies. With a mission to promote healing and the regeneration of tissue, Celling Biosciences stands at the forefront of developing cutting-edge solutions in the biotechnology space. As of now, the last investment and its associated details are not available, but the company's pioneering work in the field signals a promising trajectory.